CINECA IRIS Institutional Research Information System

CAMPION, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.676
EU - Europa 1.008
AS - Asia 900
SA - Sud America 207
OC - Oceania 68
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.907
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.537
IT - Italia 320
CN - Cina 259
BR - Brasile 146
SG - Singapore 143
TR - Turchia 123
GB - Regno Unito 111
IN - India 90
FR - Francia 79
CA - Canada 78
IE - Irlanda 75
ES - Italia 73
SE - Svezia 65
AU - Australia 61
MX - Messico 47
PL - Polonia 38
SA - Arabia Saudita 38
DE - Germania 37
BE - Belgio 35
PK - Pakistan 33
JP - Giappone 32
IR - Iran 28
ID - Indonesia 27
EG - Egitto 25
KR - Corea 25
AT - Austria 21
CL - Cile 18
NL - Olanda 18
RU - Federazione Russa 18
AE - Emirati Arabi Uniti 16
HK - Hong Kong 16
IL - Israele 16
DK - Danimarca 15
TW - Taiwan 15
AR - Argentina 14
UA - Ucraina 14
PE - Perù 13
PT - Portogallo 13
GR - Grecia 12
CZ - Repubblica Ceca 11
RO - Romania 10
DO - Repubblica Dominicana 9
FI - Finlandia 9
CH - Svizzera 8
VN - Vietnam 8
NZ - Nuova Zelanda 7
CO - Colombia 6
MA - Marocco 6
LT - Lituania 5
SK - Slovacchia (Repubblica Slovacca) 5
VE - Venezuela 5
BD - Bangladesh 4
HU - Ungheria 4
NO - Norvegia 4
PH - Filippine 4
BO - Bolivia 3
ET - Etiopia 3
GH - Ghana 3
IQ - Iraq 3
IS - Islanda 3
JO - Giordania 3
MY - Malesia 3
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
EC - Ecuador 2
KW - Kuwait 2
LB - Libano 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
ZA - Sudafrica 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CU - Cuba 1
EU - Europa 1
GT - Guatemala 1
KZ - Kazakistan 1
PA - Panama 1
RE - Reunion 1
TN - Tunisia 1
Totale 3.907
Salva come PNG Salva come JPEG
Città #
Chandler 238
Santa Clara 175
Singapore 124
Redwood City 97
Beijing 82
Dublin 71
Ann Arbor 62
Fairfield 37
Torino 36
Ashburn 32
Wilmington 31
Istanbul 30
Ottawa 29
Dearborn 27
Nyköping 26
Columbus 25
Guangzhou 24
Houston 23
Medford 22
Princeton 22
Riyadh 22
Woodbridge 21
Ankara 20
Jacksonville 20
Shanghai 19
Turin 19
Vienna 19
Jakarta 17
Lahore 17
Brussels 16
London 15
Seattle 15
Zhengzhou 14
Boston 13
Taipei 13
Madrid 12
Rome 12
Hangzhou 11
Melbourne 11
São Paulo 11
Chester 10
Izmir 10
New York 10
Dubai 9
Falls Church 9
Toronto 9
Bologna 8
Frankfurt am Main 8
Tokyo 8
Villeurbanne 8
Cairo 7
Cambridge 7
Chongqing 7
Gurgaon 7
Islamabad 7
Mountain View 7
Nanjing 7
Rio De Janeiro 7
Santo Domingo 7
Seoul 7
Sydney 7
Warsaw 7
Bengaluru 6
Calgary 6
Casalecchio di Reno 6
Cassino 6
Coimbatore 6
Edinburgh 6
Hefei 6
Lisbon 6
Milan 6
Pisa 6
Salvador 6
Sheffield 6
Washington 6
Adana 5
Belo Horizonte 5
Bratislava 5
Dehradun 5
Fortaleza 5
Gangnam-gu 5
Lima 5
Livorno 5
Montreal 5
Nanchang 5
New Delhi 5
Rio de Janeiro 5
Rovereto 5
Santiago 5
Seregno 5
Tianjin 5
Winston Salem 5
Adelaide 4
Antwerp 4
Athens 4
Barcelona 4
Brno 4
Central District 4
Davis 4
Dong Ket 4
Totale 1.898
Salva come PNG Salva come JPEG
Nome #
The role of microbiota in autism spectrum disorders 2.107
Non-invasive score system for fibrosis in chronic hepatitis: Proposal for a model based on biochemical, FibroScan and ultrasound data 354
Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy 105
Response to treatment and mortality in patients with acute-on-chronic liver failure according to the new definition of hepatorenal syndrome: a single center 3-year retrospective analysis 90
Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm 89
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 82
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis 79
Gastrointestinal tract disorders in the elderly 77
Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy 75
Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality? 74
Risk of contrast-induced acute kidney injury in cirrhotic patients undergoing computed tomography: myth or reality? 73
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 73
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology 72
Efficacy of transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease 69
Efficacy of transjugular intrahepatic porto systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease 68
Terlipressin vs noradrenalin for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: a 5-year retrospective analysis 67
HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms 64
Terlipressin vs noradrenalin for the treatment of hepatorenal syndrome in patients with acute-on-chronic liver failure: 1 5-year retrospective analysis 62
Liver involvement in adult-onset Still's disease: our experience in a third level liver unit and review of the literature 60
Non-invasive biomarkers for the detection of hepatocellular carcinoma 59
Assessment of glomerular filtration rate in patients with cirrhosis: available tools and perspectives 56
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis 54
Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome - chronic kidney disease: Impact on renal function 28
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis 21
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis 20
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial 19
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis 18
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 15
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium 15
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 14
LIVER CIRRHOSIS, CONTRAST-INDUCED ACUTE KIDNEY INJURY AND EARLY KIDNEY TUBULAR DAMAGE BIOMARKERS: A PROSPECTIVE CONTROLLED STUDY. 10
null 4
Totale 4.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.770
article - articoli 0
book - libri 0
conference - conferenze 1.295
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.065
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020470 0 0 0 0 0 32 68 82 106 73 59 50
2020/2021706 52 28 85 71 57 61 49 48 78 73 51 53
2021/2022682 36 36 42 54 48 29 52 41 64 65 138 77
2022/2023883 77 75 38 108 68 135 79 62 102 30 68 41
2023/2024494 52 61 53 42 47 38 24 38 11 48 34 46
2024/2025546 30 60 64 62 253 77 0 0 0 0 0 0
Totale 4.073